Dimensional Fund Advisors LP Kura Oncology, Inc. Transaction History

Dimensional Fund Advisors LP

$376 Billion
Q2 2024

A detailed history of Dimensional Fund Advisors LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 894,619 shares of KURA stock, worth $16.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

894,619

Previous 1,363,435 34.38%

Holding current value

$16.3 Million

Previous $29.1 Million 36.66%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$17.53 - $22.98 $8.22 Million - $10.8 Million	-468,816 Reduced 34.38%	894,619 $18.4 Million
Q1 2024 May 10, 2024	SELL	$13.42 - $23.53 $8.57 Million - $15 Million	-638,319 Reduced 31.89%	1,363,435 $29.1 Million
Q4 2023 Feb 07, 2024	BUY	$7.58 - $14.38 $1.5 Million - $2.84 Million	197,530 Added 10.95%	2,001,754 $28.8 Million
Q3 2023 Nov 09, 2023	SELL	$8.44 - $11.86 $906,726 - $1.27 Million	-107,432 Reduced 5.62%	1,804,224 $16.5 Million
Q2 2023 Aug 09, 2023	BUY	$9.62 - $13.99 $736,622 - $1.07 Million	76,572 Added 4.17%	1,911,656 $20.2 Million
Q1 2023 May 12, 2023	BUY	$10.71 - $14.6 $1.43 Million - $1.96 Million	133,912 Added 7.87%	1,835,084 $22.4 Million
Q4 2022 Feb 09, 2023	BUY	$11.23 - $16.9 $1.44 Million - $2.17 Million	128,515 Added 8.17%	1,701,172 $21.1 Million
Q3 2022 Nov 10, 2022	BUY	$12.01 - $19.45 $2.32 Million - $3.75 Million	193,042 Added 13.99%	1,572,657 $21.5 Million
Q2 2022 Aug 12, 2022	BUY	$10.71 - $18.33 $3.31 Million - $5.66 Million	308,930 Added 28.85%	1,379,615 $25.3 Million
Q1 2022 May 13, 2022	BUY	$11.78 - $16.98 $3.49 Million - $5.03 Million	296,175 Added 38.24%	1,070,685 $17.2 Million
Q4 2021 Feb 09, 2022	BUY	$12.22 - $19.57 $1.52 Million - $2.43 Million	124,269 Added 19.11%	774,510 $10.8 Million
Q3 2021 Nov 12, 2021	SELL	$15.42 - $21.72 $1.7 Million - $2.39 Million	-110,066 Reduced 14.48%	650,241 $12.2 Million
Q2 2021 Aug 12, 2021	SELL	$20.85 - $29.88 $1.23 Million - $1.76 Million	-58,785 Reduced 7.18%	760,307 $15.9 Million
Q1 2021 May 14, 2021	BUY	$24.75 - $39.14 $4.22 Million - $6.68 Million	170,582 Added 26.3%	819,092 $23.1 Million
Q4 2020 Feb 25, 2021	BUY	$29.0 - $41.62 $18.8 Million - $27 Million	648,510 New	648,510 $21.2 Million

Others Institutions Holding KURA

# of Institutions

181

Shares Held

80.2M

Call Options Held

148K

Put Options Held

63K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.22B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Kura Oncology, Inc. Transaction History